Three protagonists of the medical research field in Spain debated in a new edition of the “Pioneros Santander” forum, organized virtually by El País Retina. Elisabeth Engel, group leader of Biomaterials for regenerative therapies at the Institute for Bioengineering of Catalonia (IBEC), Rocío Arroyo, CEO of Amadix and Eduardo Jorgensen, of Medicsen, also CEO, agreed to celebrate the greatest interest in their area of work, the intersection between science, technology and health, but at the same time they were cautious: there are no shortcuts in the most cutting-edge research, neither before Covid-19 nor after.
Researchers at the Institute of Bioengineering of Catalonia (IBEC) led by Núria Montserrat have found in vitro that diabetes is a disease that accelerates Covid-19. In the lab, they have also created mini-hearts to study the heart problems caused by Covid-19.
A team of international scientists led by the Institute for Bioengineering of Catalonia (IBEC) has developed a “faster, more effective and safer” therapy to eliminate infections of intracellular bacteria that cause diseases such as tuberculosis. Scientists participating in the study include Group Leader Giuseppe Battaglia and the researcher Loris Rizzello of IBEC.
Josep Samitier, director of the Institute for Bioengineering of Catalonia and president of the Catalan Association of Research Entities (ACER), assesses how science and technology can be affected by the fact that 53 million euros, that had to be invested in research, have been redirected to the healthcare sector, due to the coronavirus outbreak.
Àngels Suarez, teacher at Gayarre school, explained the alliance between IBEC and the Gayarre School within the frame of the project “Magnet, alliances for educational success”. This initiative unites educational centres that have an unbalanced social composition with an institution of excellence for 4 years. This union will allow the educational centre to develop an innovative project that will become a reference project in its territory. During her intervention, she also shared with the audience a virtual experiment, easy to perform in our homes, to explain the density.
ERC grantee Nuria Montserrat and her team create tiny kidneys which are proving to be key in the search for coronavirus drugs. The researcher is working with other international researchers and found that a trial drug could block early stages of COVID19. The ERC has created a section which is updated with the latest news about the ERC-funded research in coronavirus.
One of the most prestigious German newspapers, the Süddeutsche Zeitung echoes the work of Núria Montserrat and her international partners who are investigating with organoids a drug that blocks the entrance door of Covid19.
Nuria Montserrat, principal investigator of the “Pluripotency for organ regeneration” and her group have participated in an international study to find a treatment to stop the virus from continuing infecting other cells, preventing the virus from replicating.
IBEC appears on the catalan news on TV3, where they summarise the various Catalan initiatives to fight against Covid-19.
Nuria Montserrat, principal investigator of the “Pluripotency for organ regeneration” spoke today at Espejo Público about the research that her group is carrying out in collaboration with other international research groups to find a treatment to stop the virus from continuing infecting other cells, preventing the virus from replicating.